GCP
PAVM icon

GSA Capital Partners’s PAVmed PAVM Stock Holding History

GSA Capital Partners’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,197
Closed -$15K – 2056
2025
Q4 		$15K Buy
+2,197
New +$25.1K ﹤0.01% 1607
2022
Q2 		– Sell
-357
Closed -$212K – 1702
2022
Q1 		$212K Buy
357
+26
+8% +$19.3K 0.03% 1147
2021
Q4 		$367K Buy
+331
New +$719K 0.05% 803

Other funds holding PAVM

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GSA Capital Partners's PAVM Position: Q1 2026 in Review

GSA Capital Partners sold out of PAVmed (PAVM) in Q1 2026, closing a stake of 2,197 shares — an estimated $15K sold.

GSA Capital Partners first reported a position in PAVM in Q4 2021 and held it in 3 quarters. The position peaked at $367K in Q4 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • GSA Capital Partners reported no remaining PAVmed position as of Q1 2026 after selling out during the quarter.
  • GSA Capital Partners sold 2,197 PAVmed shares in Q1 2026, an estimated $15K.
  • GSA Capital Partners first reported a position in PAVmed in Q4 2021 and held it in 3 quarters.
  • GSA Capital Partners's PAVmed position peaked at $367K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.